Status: current, Defined. Date: 30-Jun 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 455951000036111 | Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 455961000036114 | Eligard 3 Month (inert substance) diluent [1 syringe] (&) (leuprorelin acetate 22.5 mg) modified release injection [1 x 22.5 mg syringe], 1 pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | has container type | pack | true | Inferred relationship | Some | ||
| Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | has TP | Eligard 3 Month | true | Inferred relationship | Some | ||
| Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | Is a | Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | true | Inferred relationship | Some | ||
| Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | has container type | composite pack | false | Inferred relationship | Some | ||
| Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | has TPUU | Eligard 3 Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg syringe | true | Inferred relationship | Some | 1 | |
| Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | has TPUU | Eligard 3 Month (inert substance) diluent, syringe | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bi Eligard CP 3 Month (1 x Eligard 3 Month pack, 84 x Bicalutamide (MPL) tablets), 1 pack | has component pack | True | Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | Inferred relationship | Some | |
| Bi Eligard CP 3 Month (1 x Eligard 3 Month pack, 28 x Bicalutamide (MPL) tablets), 1 pack | has component pack | True | Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | Inferred relationship | Some | |
| Bi Eligard CP 3 Month (1 x Eligard 3 Month pack, 28 x Bicalutamide (Tolmar) tablets), 1 pack | has component pack | True | Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | Inferred relationship | Some | |
| Bi Eligard CP 3 Month (1 x Eligard 3 Month pack, 84 x Bicalutamide (Tolmar) tablets), 1 pack | has component pack | True | Eligard 3 Month (1 x 22.5 mg syringe, 1 x inert diluent syringe), 1 pack | Inferred relationship | Some |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR